Mechanisms responsible for the reductions in renal blood flow (RBF) and glomerular filtration rate (GFR) in response to acute infusions of amphotericin B were investigated in vivo in rats. The influence of salt status and the roles of adenosine, cyclic AMP, and calcium influx were examined. Amphotericin B was infused into the renal artery in seven groups of rats at 0.025 mg/kg of body weight per min for 15 min. RBF Amphotericin B infusions induce acute reductions in renal blood flow (RBF) and glomerular filtration rate (GFR) in both rats and dogs (4, 9, 11), due mostly to elevation of renovascular resistance (21). The mechanisms underlying these acute hemodynamic effects have not been completely elucidated. Studies with dogs have suggested that activation of tubuloglomerular feedback (TGF) plays a role in these changes, since both TGF and amphotericin B-induced decreases in GFR are inhibited by the same pharmacologic interventions (salt loading, furosemide, or theophylline administration) (1, 7, 8, 24, 31) . Unfortunately, these studies were conducted with different species (dogs for amphotericin B and rats for TGF). It is not clear whether both species behave similarly with respect to both TGF and amphotericin B. Therefore, it is important to examine this question since, if true, it would lend greater support to the hypothesis.
Mechanisms responsible for the reductions in renal blood flow (RBF) and glomerular filtration rate (GFR) in response to acute infusions of amphotericin B were investigated in vivo in rats. The influence of salt status and the roles of adenosine, cyclic AMP, and calcium influx were examined. Amphotericin B was infused into the renal artery in seven groups of rats at 0.025 mg/kg of body weight per min for 15 min. RBF and GFR were measured over 15 min before, during, and after the infusion. Control rats were maintained on a normal salt diet; a second group of rats received a salt-depleted diet, and a third group received a high-salt intake. Four other groups were kept on a normal diet and received theophylline (0.5 ,umol/kg/min into the renal artery, intra-arterially [i.a.]), dibutyryl cyclic AMP (85 ,ug/min, i.a.), the 5'-nucleotidase inhibitor adenosine a4.-methylene diphosphate (4 mg/kg, intramuscularly), or diltiazem (20 ,ug/kg/min, i.a.). Control rats had a prompt 50% decrease in RBF in response to amphotericin B. This was sustained over the 15-min infusion period and was accompanied by a decrease in creatinine clearance (CLCR) (from 0.83 0.08 to 0.40 + 0.09 mn/min; P < 0.05). On stopping the infusion, RBF returned quickly to baseline but CLCR continued to decrease further (to 0.35 ± 0.07 m/min; P < 0.05). Salt loading, theophylline, and diltiazem administration prevented the decreases in both RBF and CLCR. Both RBF and CLCR responses in the remaining groups were not significantly different from those in controls. The results of this study reveal a protective effect of salt loading and theophyiline against amphotericin B nephrotoxicity in the rat but deny a role for adenosine in mediating these effects. They further suggest that theophylline inhibits the acute responses by a mechanism unrelated to either adenosine receptor blockade or phosphodiesterase inhibition and that calcium influx into the cells is probably responsible for the acute changes in RBF and GFR in response to amphotericin B.
Amphotericin B infusions induce acute reductions in renal blood flow (RBF) and glomerular filtration rate (GFR) in both rats and dogs (4, 9, 11) , due mostly to elevation of renovascular resistance (21) . The mechanisms underlying these acute hemodynamic effects have not been completely elucidated. Studies with dogs have suggested that activation of tubuloglomerular feedback (TGF) plays a role in these changes, since both TGF and amphotericin B-induced decreases in GFR are inhibited by the same pharmacologic interventions (salt loading, furosemide, or theophylline administration) (1, 7, 8, 24, 31) . Unfortunately, these studies were conducted with different species (dogs for amphotericin B and rats for TGF). It is not clear whether both species behave similarly with respect to both TGF and amphotericin B. Therefore, it is important to examine this question since, if true, it would lend greater support to the hypothesis.
In chronic models of nephrotoxicity in the rat, salt loading attenuates the decreases in GFR induced by amphotericin B, while salt depletion potentiates them (16, 28) . In addition, there are hemodynamic changes similar to those observed after acute infusions of the drug (28) . At present, the effect of salt status on the acute renal response of the rat to amphotericin B is unknown, but it is possible that the acute hemodynamic effects of amphotericin B may contribute to the deterioration in renal function observed in chronic models. In order to examine this possibility and to further study the role of TGF, we decided to assess the influence of salt status on the acute responses to amphotericin B in rats.
Theophylline inhibits the GFR-lowering effects of both * Corresponding author.
TGF activation in rats (17, 18) Protocol. Rat plasma was administered after opening the abdomen at a rate of 10 ml/kg/h for 45 min followed by 1.5 ml/kg/h for the remainder of the experiment to replace fluid losses. After surgery was completed, rats were allowed to stabilize for 45 to 60 min. The experiment consisted of three observation periods of 15 min each, during which RBF and RPP were continuously monitored and urine samples were collected. Period 1 was the baseline period and was followed by a 15-min infusion of amphotericin B at 0.025 mg/kg/min into the extracorporeal shunt (intra-arterially i.a.), after which there was the final (postinfusion) period. Plasma samples were collected during period 1 and at the end of period 3. Concentrations of creatinine in urine and plasma were measured with a Beckman creatinine autoanalyzer (Beckmann Instruments Inc., Fullerton, Calif.), and creatinine clearance (CLCR) was calculated during each period by using the formula UCR V/PCR, where UCR and PCR are the concentrations of creatinine in urine and plasma, respectively, and V is urine flow rate. Renal resistance for each period was calculated by averaging the individual resistance values at 1-min intervals during that period.
Seven groups of rats were studied. Each group consisted of seven rats except for the salt-loaded and diltiazem-treated groups, in which six rats were used. The control group consisted of rats maintained on a normal-salt diet. Another group of rats (-NaCl rats) was maintained on a low-salt diet (Na composition, <0.05%; Ralston Purina Co., St. Louis, Mo.) and tap water for at least 1 week prior to the day of the experiment. A third group was kept in a high-salt status (+NaCl rats) by subcutaneous injection of 10 mg of deoxycorticosterone acetate 1 week prior to the day of the experiment, followed by maintenance on a normal-salt diet and 1.0% saline drinking water. This manipulation of the diets has been shown to result 1 week later in Na depletion and Na loading as reflected by the urinary Na excretion rate (18) . In addition, +NaCl rats received an infusion of 0.9% saline at a rate of 0.1 m/min to maintain volume expansion. This infusion was started at the time of surgery and maintained throughout the experiment and has been previously used to inhibit TGF activity. The remaining groups of rats received a normal-salt intake and one of the following interventions: (i) theophylline (5 ,umol/kg/min for 10 min, and then 0.5 gxmol/kg/min into the extracorporeal system (i.a.), started 30 min prior to amphotericin B, and continued throughout the experiment). This dose has been shown to inhibit responses to exogenous adenosine in previous studies with rats (4, 17) as well as pilot experiments in this model. It also is similar to the dose that inhibits TGF activation (6) and amphotericin B-induced fall in RBF in rats (4); (ii) AMP-CP (4 mg/kg intramuscularly 2 h prior to amphotericin B). This dose has previously been shown to cause a maximnal inhibition of 5'-nucleotidase activity 2 h after intramuscular injection (15); (iii) DB-cAMP (85 ,ug/kg/min i.a., started 30 min prior to amphotericin B and continued throughout the experiment). This dose has previously been shown to induce biological effects in the kidney, without significantly altering the baseline RBF (14) ; and (iv) diltiazem (20 ,g/kg/min, i.a., started 30 min prior to amphotericin B and continued throughout the experiment). This dose was found, in pilot experiments, to be the highest tolerated dose without changing baseline renal vascular resistance.
Statistical analysis. Values are presented as means + standard error of the mean. Changes in RBF within each group were compared with baseline by one way analysis of variance (ANOVA) followed by Newman-Keuls test for multiple comparisons. Comparison of the RBF response between control and experimental groups was done by repeated measures ANOVA. CLCR was compared within and between groups by two-way ANOVA, one factor being treatment group and the other being the experimental period. The paired Student's t test was then used for comparison of individual time points within each group. A P value of <0.05 was considered statistically significant.
RESULTS
Baseline RBF, RPP, and calculated renal resistance values in each of the study groups are presented in Table 1 . The only difference from control in baseline RBF was in the salt-loaded group, in which it was significantly higher. In addition, RPP was significantly lower than control in both the theophylline and diltiazem groups. Since both RBF and RPP were essentially stable during each period except for the first 1 to 2 min of the second and third periods, we were able to calculate values for average total renal resistance (RT) for each period. Calculation of baseline RT revealed significant differences only between the control and theophylline groups.
The urinary sodium excretion rates during the baseline period were calculated in the control, -NaCl, and +NaCl groups to evaluate the adequacy of the dietary manipulation. The control and -NaCl groups had similar values of 0.07 ± (Fig. 1) . Upon stopping amphotericin B, there was a similarly rapid return of RBF toward the baseline level. Measurement of CLCR during these three periods revealed a decrease during the amphotericin B infusion (from 0.83 ± 0.08 to 0.40 ± 0.09 ml/min; P < 0.05) ( Table 2 ). Despite the return of RBF to baseline in the postinfusion period, there was a progressive fall in CLCR (to 0.35 ± 0.07 ml/min; P < 0.05).
In the salt-loaded group, both RBF and GFR responses were significantly inhibited. There was no significant change in RBF over the first 11 min of the drug infusion in this group of rats, but during the last 3 min, there was a progressive reduction in RBF (Fig. 1) . Since the baseline RBF was higher in +NaCl rats, this drop (25%) is a much smaller percent decrease than that in the control group (50%). ANOVA revealed a significant difference in the RBF response over time compared with that in the control group control) (n = 7 in each group). Each point represents the mean ± standard error of the mean. Repeated measures by ANOVA compared theophylline with control (P < 0.0001) and DB-cAMP and control (P = 0.04). *, P < 0.05 compared with the same time point in the control group. < 0.0001). Baseline CLCR was significantly higher in this group compared with that in the rest (P < 0.02) but did not change significantly over the three experimental periods (Table 2 ). In contrast the RBF response in the salt-depleted group was almost identical to that of the control group (Fig.  1) , with repeated measures ANOVA showing no significant differences between the two. The decrease in CLCR also followed a similar pattern (Table 2) .
Pretreatment with theophylline resulted in a higher baseline RBF and a lower renal resistance (Table 1) . Theophylline significantly inhibited the reduction in RBF induced by amphotericin B (Fig. 2) . When compared with the control group there was a significant effect of theophylline treatment on the RBF response for the experimental period. In addition, CLCR remained at baseline values throughout the experimental period (Table 2) .
In order to analyze the mechanism by which theophylline prevented the effects of amphotericin B on the kidney, either DB-cAMP or AMP-CP was administered to rats. Neither drug substantially modified the fall in RBF (Fig. 2) . In the DB-cAMP-treated group, the vasoconstrictor response dur- Time (mmn) (1) . However, alternative explanations, exist. Given the ,ffects of diltiazem (A) (n = 6) on RBF response to slightly reduced renal resistance in the +NaCl group, it n B (0.025 mg/kg/min, i.a.) (0, control) (n = 7). Each could be argued that the vasculature became unresponsive to ents the mean ± standard error of the mean. Repeated contraction. A similar argument can be used to explain the NOVA revealed P < 0.001. *, P < 0.05 compared with protective effects of theophylline in this study, such that it ne point in the control group.
would be acting as a functional antagonist of amphotericin B.
Prior studies, however, have revealed that vasodilation per .ision period was not significantly different from se, with hydralazine (4) ±. 1. showt n thatce b theo hlmeihibitsethevRBF anudGFR raet-infusion, 14.5 ± 0.13 mm Hg/min/ml). Thus, the shown that theophyllne inhibits the RBF and GFR rere essentially similar to the control group. Calcusponses to amphotericin B infusions in dogs (9) . In rats, it -LCR in these two groups revealed significant has an inhibitory effect on the RBF response (11), but the over the two consecutive periods (Table 2) , and GFR response has not been studied. In this study, we were ges were similar to the control group. able to confirm an inhibitory effect of theophylline on the fall treatment with diltiazem caused a significant in both RBF and CLCR.
in baseline RPP but not in baseline resistance
Here, it is necessary to emphasize the need for conducting rhe RBF response to amphotericin B in this group these experiments in rats. As can be seen from the results r to that observed in the theophylline-treated with salt loading, it is now clear that this measure inhibits the 3t). Diltiazem was also successful in preventing acute renal effects of amphotericin B in rats and dogs, its se in GFR (Table 2) . chronic effects in rats and in humans, and its acute and chronic effects in rats. This finding suggests that the mech-DISCUSSION anisms of action of the drug in the three species is similar.
The similar results obtained by using theophylline with rats ilts of this study confirm that the decreases in RBF and dogs support this. Therefore, it is now possible to tssociated with acute administration of amphoterinvestigate the mechanisms of action of this agent in one ats are inhibited by salt loading and theophylline species (rats, since they are the easiest to work with) and be tion. They further suggest that these changes are more confident in extrapolating the results to others, notaactivation of calcium fluxes into cells. They, bly, humans. Furthermore, as mentioned in the IntroducJo not support a role for adenosine in mediating tion, the role of TGF was based on studies conducted in ges.
different species which may differ not only in their response ng the effects of changing the salt status on the to amphotericin B but also in their intrarenal regulatory dium excretion rate revealed that, despite maniphomeostatic mechanisms such as TGF. the diet, the control and salt-depleted rats had Three alternative mechanisms of action have been attrib-)w values. This suggested that the model that was uted to theophylline. These include adenosine receptor duced significant stress to render the kidney salt blockade, phosphodiesterase inhibition, and changes in inIn contrast, the salt-loaded group had elevated tracellular calcium levels (17) . cessful in antagonizing the RBF-lowering effects of amphotericin B (13) . Using AMP-CP as an alternative pharmacological probe of the role of adenosine, we were also unable to substantially alter the response to amphotericin B. Conversely, there was a tendency for AMP-CP to potentiate the response. The dose of AMP-CP used here had been shown to inhibit the activity of 5'-nucleotidase in response to ischemia to the rat kidney by 80% at 2 h postinjection. These results, therefore, strongly argue against a role for adenosine in mediating the changes in RBF and GFR in response to amphotericin B. Since adenosine is considered a putative mediator for TGF (17, 18, 25) , this result suggests that TGF is not involved in these responses. However, it should be noted that several other messengers have been proposed for the efferent limb of TGF, including arachidonic acid metabolites, angiotensin, and calcium (2, 15, 30) .
Although the group treated with DB-cAMP tended to have an attenuated response during the first few minutes of the infusion, the overall response was not significantly better than that in the control group. In fact, during the latter stages of the experiment the RBF was lower. It is, therefore, unlikely that theophylline-induced phosphodiesterase inhibition was responsible for the modification by theophylline of the renal effects of amphotericin B.
Finally, and in order to examine the role of intracellular calcium levels in mediating the effects of amphotericin B and their inhibition by theophylline, we used the voltage-dependent calcium channel blocker diltiazem. As the results demonstrate, diltiazem protected the kidney against the amphotericin B insult. These results with diltiazem are similar to those obtained by Tolins and Raij (27) who, using the structurally different calcium channel blocker verapamil, demonstrated a marked inhibition of the amphotericin B-induced decrease in RBF and a significant attenuation of that in GFR. Therefore, these two studies strongly suggest that voltage dependent calcium entry has a pivotal role in mediating the acute hemodynamic effects of amphotericin B.
Regarding the role of TGF in mediating the effects of amphotericin B, the results of this study are inconclusive. While the protection by salt loading is supportive of such a role, the evidence against involvement of adenosine is contradictory. The protection by diltiazem can be explained in many ways, one of which is inhibition of TGF (2), but there are also vasodilation and calcium channel blockade in the effector cells. Since submission of the manuscript, however, new findings have provided evidence against a relationship between the acute renal effects of amphotericin B and activation of TGF. A study by Sawaya et al. examined the role of TGF directly by using micropuncture techniques (22) . The authors found no difference between single nephron GFR measured in proximal (TGF interrupted) or distal (TGF intact) tubules. Nor was there any effect of amphotericin B on distal chloride concentration or on TGF sensitivity. The drug, however, contracted isolated renal arteries and arterioles, an effect that was inhibited by removal of calcium from the bathing medium, by calcium channel blockade with verapamil, and by the presence of theophylline. We have also observed a similar response in cultured glomerular mesangial cells, in which amphotericin B induced a rise in cytosol-free calcium concentrations suggestive of contraction, which was inhibited by removal of extracellular calcium and by diltiazem (20) . Thus, it is probable that the effects observed with diltiazem in the present study involve inhibition of calcium channel activity in the cells that are being contracted by amphotericin B. The in vitro inhibition of contraction by theophylline also points to a mechanisms unrelated to inhibition of TGF by the xanthine. Thus, it is also probable that amphotericin B acts directly on contractile cells, in vivo as it does in vitro, possibly by altering membrane permeability. Alternatively, it may induce these cells to release vasoactive agents which result in a contractile response.
The ability of both diltiazem and theophylline to prevent the RBF changes secondary to amphotericin B raise the possibility that the xanthine may be acting on calcium channels. The effects of xanthines on intracellular calcium levels vary according to the type of tissue used. In skeletal and cardiac muscle, these drugs increase calcium levels and potentiate contractions (19) . In intestinal smooth muscle, they cause relaxation of muscle tone and decrease intracellular calcium levels, mainly because of inhibition of calcium entry and partly because of increased binding of calcium by intracellular proteins (12) . It is possible that the protective effect of theophylline in the present study may relate to some degree of calcium channel blockade. Alternatively, the effects of the two drugs may be totally unrelated.
